N. Y. Oshmyanska

N. Y. Oshmyanska

Auto-generated profile, based on publicly available information

N. Y. Oshmyanska

SI “Institute of Gastroenterology of the NAMS of Ukraine”, Dnipro, Ukraine

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 September 2021 in GASTROENTEROLOGY
Verified
Journal Article
Open access
PDF file
YSYu.M. Stepanov
Yu.M. Stepanov
ОKО.м. Kovalenko
О.м. Kovalenko
NON.YU. Oshmyanska
N.YU. Oshmyanska
У роботі за допомогою сучасних гістологічних, гістохімічних і морфометричних методів дослідження проаналізовано біоптати 120 хворих на хронічний рефлюкс-гастрит. Під час гістологічного дослідження слизової оболонки шлунка атрофічні процеси спостерігалися у 73,3 % випадків, при цьо­му у 46,7 % до атрофії приєднувалися більш глибокі ураження: кишкова метаплазія та гіперплазія, а у 15 % випадків — дисплазія шлункових залоз. Авторами запропоновано використання інтегрального показника «кишкова метаплазія + дисплазія» як додаткового критерію оцінки тяжкості передракових змін слизової оболонки шлунка у хворих на хронічний рефлюкс-гастрит, вірогідно пов’язаного з гіперплазією шлункових залоз, інфекцією H.руlori, підвищенням рівня нітритів і тенденцією до збільшення рівня нітратів і гастрину.

10 April 2021 in Acta Biomedica Scientifica
Verified
Journal Article
Open access
PDF file
JCJ. Chen
J. Chen
PZP. Zhou
P. Zhou
WTW. Tan
W. Tan
WZWuyan Zheng
Wuyan Zheng
NON. Y. Oshmianska
N. Y. Oshmianska
НОН. Ю. Ошмянская
Н. Ю. Ошмянская
Background. Gout is frequently accompanied by hypertension, obesity, and/or impaired glucose tolerance, which are often complicated with heavy smoking and dietary violations, especially in male patients.Objective. To determine the behavioral characteristics of gout patients that could impact the results of urate lowering therapy.Subjects and methods. The relationship between behavioral characteristics and results of urate lowering therapy were investigated in 74 male gout patients of Chengdu Rheumatism Hospital. The results of treatment were evaluated using serum uric acid contents before and after treatment, VAS pain score before and after treatment. Behavioral characteristics for the last ten years (smoking status, daily volume of drinking water, etc.) were accessed by means of retrospective survey.Results. In gout patients with poor treatment response, serum uric acid at the beginning of the treatment was already significantly lower (365.76 ± 163.06 μmol/L); this trend was also noted in a “slow progress” group, while patients with higher serum uric acid before treatment had notably better response to urate lowering therapy. During further analysis age negatively correlated with serum uric acid (r = –0.328; p = 0.002) and uric acid clearance ratio (r = –0.299; p = 0.002).In patients with uric acid clearance ratio above 40 % the prevalence of kidney diseases (stones or dysfunction) was significantly lower compared to other groups. There was no significant influence of hypertension, diabetes mellitus, fatty liver or hyperlipidaemia on uric acid clearance ratio (p > 0.05).Amount of drinking water also influenced the serum uric acid clearance ratio. Bigger amount of patients in the “fast progress” group (40.0 % compared to 30.44 and 25.0 %) tended to drink more water.Conclusion. In most gout patients, serum uric acid levels before treatment acted as the reliable predictor of good response to urate lowering therapy. Treatment response (serum uric acid clearance ratio) correlated positively with the hyperuricemia and drinking sufficient amounts of water, negatively – with prolonged smoking (more than 10 years) and age.

26 July 2016 in GASTROENTEROLOGY
Verified
Journal Article
Open access
PDF file
YSYu.M. Stepanov
Yu.M. Stepanov
YHYu.A. Haidar
Yu.A. Haidar
VDV.I. Didenko
V.I. Didenko
OHO.P. Halenko
O.P. Halenko
NON.YU. Oshmyanska
N.YU. Oshmyanska
Проведено морфологічний аналіз мікроструктурних змін гепатоцитів у хворих на хронічний вірусний гепатит С, розподілу маркерів апоптозу та білків цитоскелета на матеріалі 41 пункційної біо­псії печінки. За допомогою імуногістохімії та комп’ютерної морфометрії проаналізовано мікроструктурні зміни, що супроводжують прогресування фіброзу, вивчено особливості механізму апоптозу гепатоцитів, локалізації цитохрому С, зміни системи мікрофіламентів і скорочувальних властивостей актину з паралельною активацією процесів регенерації.

16 June 2022 in GASTROENTEROLOGY
Verified
Journal Article
Open access
PDF file
VDV.I. Didenko
V.I. Didenko
VKV.A. Karachynova
V.A. Karachynova
IKI.A. Klenina
I.A. Klenina
YGYu.а. Gaidar
Yu.а. Gaidar
NON.YU. Oshmianska
N.YU. Oshmianska
NVN.S. Vishnarevskaya
N.S. Vishnarevskaya
Background. Today most of the scientists are studying the processes of hepatocyte damage under the influence of free fatty acids (FFA) in vitro conditions. Therefore, in vivo studies of the spectrum of FFA in liver pathologies of different genesis, including toxic ones, are of considerable interest. Materials and methods. Toxic liver damage was simulated by subcutaneous injection of CCl4 solution in olive oil into rats. The following groups were formed: control (healthy; n=15); I— CCl4-induced liver damage without drug correction (n=6); III— CCl4-induced liver damage + metadoxin (Liveria IC; n=8); III— CCl4-induced liver damage + metabiotic (Hilac forte) (n=7). For morphological assessment of steatosis and fibrosis we used three-color qualitative staining of liver samples by Mallory-Slinchenko. Quantitative content of monounsaturated fatty acids (MUFA) in liver homogenate was determined by gas chromatography. Results. Evaluation of hepatobioptates in group I rats revealed tissue disorganization with macrovesicular steatosis in the cytoplasm of hepatocytes, the formation of interparticle multiple fibrous septa and inflammatory cell infiltration. The use of metadoxin (group II) and metabiotic (group III) improved the morphological picture of the liver, which was damaged by CCl4. Total MUFA content increased significantly in 118 (p<0.001), 34 (p<0.001) and 99 times (p<0.001), respectively, for groups I–III animals relative to control, but in group II— tended to decrease in 3.5 (p=0.430) and 2.9 times (p=0.064), compared to groups I and III, respectively. Conclusions. It was found that correction with methadoxin and metabioticreduced the manifestations of protein-fatty dystrophy in hepatocytes. In all animal research groups, the content of PUFA increased mainly due to significant concentrations of cis-10-pentadecenoic, cis-10-heptadecenoic, trans- and cis-9-octadecenoic and cis-11-eicosenoic acids. MUFA content decreased more under the influence of methadoxin than metabiotic.

4 October 2014 in Visnyk of Dnipropetrovsk University. Biology, medicine
Verified
Journal Article
Open access
NON. Y. Oshmyanska
N. Y. Oshmyanska
AGA. A. Galinsky
A. A. Galinsky
YGY. A. Gaidar
Y. A. Gaidar
The study has been conducted on 39 white laboratory male rats which formed 5 groups: experimental occlusal pancreatitis caused by ligation of the main pancreatic duct (n = 6), experimental alcoholic pancreatitis caused by oral intake of alcohol (n = 6), against the background of an excess (n = 6) or deficiency (n = 6) of nitric oxide, as well as a control group (n = 15). This study provides the detailed description of the processes of death and regeneration in the islets of Langerhans, typical for early stages of the disease. The expression of the proliferation markers (PCNA and Neurogenin-3) has been analyzed using histological and immunohistochemical methods along with the changes of morphological structure, that led to initiation of the alcoholic chronic pancreatitis against the background of imbalance in NO-ergic regulatory system caused by an excess or deficiency of nitric oxide. It has been found that ligation of the pancreatic duct in the experiment reconstructedthe circumstances of chronic pancreatitis in rats and caused the activation of fibrosis and regeneration of endocrine and exocrine tissue. Compared with occlusion, the effects of ethanol on the pancreas also manifested in the activation of fibrogenesis, but the structural changes were negligible and could unlikely lead to advanced fibrosis and chronic pancreatitis in the future. On the other side, an imbalance of NO-system in alcoholic rats leads to disruption of the zymogens secretion in the acinar cells and dilatation of the capillary network in islets. Uneven distribution of zymogen granules may lead to their intracellular activation as evidenced by the deformation of acini and focal apoptosis without inflammatory response. In this case, violation of the key adaptive responses in the pancreas makes it more vulnerable to the effects of ethanol, its metabolites, and other environmental factors, and may increase the probability of chronic pancreatitis development. At the same time, forementioned process of cell death in the pancreas is considerably more prolonged, and long term course eliminates the activation of proliferation or functional tissue regeneration.

18 June 2014 in Pathologia
Verified
Journal Article
Open access
PDF file
YGY. A. Gaidar
Y. A. Gaidar
NON. Y. Oshmyanska
N. Y. Oshmyanska
AHA. P. Halenko
A. P. Halenko
Диференційна діагностика аутоімунного панкреатиту пов’язана з різним ступенем залученості в патогенез імуноглобуліну G 4 субкласу. З метою вивчення двох форм аутоімунного панкреатиту та їх зв’язку з рівнем IgG4-позитивних плазматичних клітин у підшлунковій залозі за допомогою гістологічних та імуногістохімічних методів обстежили 54 хворих на хронічний панкреатит, із них відібрано 15 випадків з аутоімунним панкреатитом. При аутоімунному панкреатиті I типу спостерігали щільний лімфоплазмоцитарний перідуктальний інфільтрат, багатоярусний фіброз, облітеруючий венуліт і високий рівень IgG4-ППК у підшлунковій залозі (≥ 30 IgG4-ППК на велике поле зору). Для аутоімунного панкреатиту II типу, крім типових патогістологічних ознак аутоімунного панкреатиту, властиві лейкоцитарне ушкодження епітелію панкреатичних проток, низький рівень IgG4-ППК у підшлунковій залозі й осередкові ураження на I–III стадіях захворювання (80% випадків).